StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)

Close on Nov 17, 2026Market cap $1.97BP/E –Yield –

NeoGenomics total assets

Total assets on the balance sheet at the end of each period.

NeoGenomics's total assets was $1.38B at Sep 30, 2026. For fiscal 2025 it was $1.36B, down 17.0% from the year before. Over ten years it grew 14.5% a year on average. The highest annual figure on record is $1.87B in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.36B-17.0%
FY2024Dec 31, 2024$1.64B-2.6%
FY2023Dec 31, 2023$1.68B-3.4%
FY2022Dec 31, 2022$1.74B-6.9%
FY2021Dec 31, 2021$1.87B+89.2%
FY2020Dec 31, 2020$988.33M+39.3%
FY2019Dec 31, 2019$709.51M+40.5%
FY2018Dec 31, 2018$505.02M+46.6%
FY2017Dec 31, 2017$344.45M+2.2%
FY2016Dec 31, 2016$337.12M-4.0%
FY2015Dec 31, 2015$351.29M+333.1%
FY2014Dec 31, 2014$81.11M+103.2%
FY2013Dec 31, 2013$39.92M+32.7%
FY2012Dec 31, 2012$30.07M+50.7%
FY2011Dec 31, 2011$19.95M+46.1%
FY2010Dec 31, 2010$13.65M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.38B+0.2%
Q2 FY2026Jun 30, 2026$1.35B-3.0%
Q1 FY2026Mar 31, 2026$1.35B-15.9%
Q4 FY2025Dec 31, 2025$1.36B-17.0%
Q3 FY2025Sep 30, 2025$1.37B-16.2%
Q2 FY2025Jun 30, 2025$1.39B-15.2%
Q1 FY2025Mar 31, 2025$1.60B-2.4%
Q4 FY2024Dec 31, 2024$1.64B-2.6%
Q3 FY2024Sep 30, 2024$1.64B-2.2%
Q2 FY2024Jun 30, 2024$1.64B-3.1%
Q1 FY2024Mar 31, 2024$1.64B-4.0%
Q4 FY2023Dec 31, 2023$1.68B-3.4%
Q3 FY2023Sep 30, 2023$1.68B-4.4%
Q2 FY2023Jun 30, 2023$1.70B-5.4%
Q1 FY2023Mar 31, 2023$1.71B-6.6%
Q4 FY2022Dec 31, 2022$1.74B-6.9%
Q3 FY2022Sep 30, 2022$1.76B-7.9%
Q2 FY2022Jun 30, 2022$1.79B-5.5%
Q1 FY2022Mar 31, 2022$1.83B+22.4%
Q4 FY2021Dec 31, 2021$1.87B+89.2%
Q3 FY2021Sep 30, 2021$1.91B+98.7%
Q2 FY2021Jun 30, 2021$1.90B+100.6%
Q1 FY2021Mar 31, 2021$1.49B+104.1%
Q4 FY2020Dec 31, 2020$988.33M+39.3%
Q3 FY2020Sep 30, 2020$959.43M+34.9%
Q2 FY2020Jun 30, 2020$945.49M+35.7%
Q1 FY2020Mar 31, 2020$732.25M+37.3%
Q4 FY2019Dec 31, 2019$709.51M+40.5%
Q3 FY2019Sep 30, 2019$711.16M+56.3%
Q2 FY2019Jun 30, 2019$696.67M+101.5%
Q1 FY2019Mar 31, 2019$533.34M+52.7%
Q4 FY2018Dec 31, 2018$505.02M+46.6%
Q3 FY2018Sep 30, 2018$455.14M+32.3%
Q2 FY2018Jun 30, 2018$345.78M+1.7%
Q1 FY2018Mar 31, 2018$349.27M+1.6%
Q4 FY2017Dec 31, 2017$344.45M+2.2%
Q3 FY2017Sep 30, 2017$343.90M–
Q2 FY2017Jun 30, 2017$339.88M–
Q1 FY2017Mar 31, 2017$343.64M–
Q4 FY2016Dec 31, 2016$337.12M–

More NeoGenomics figures

See a number that looks wrong?